MTOR and Parkinson disease: In vivo and in vitro models of PD demonstrated that exendin-4 ameliorated behavioral deficits and reduced α-synuclein pathology, and enhanced autophagy via restoration of PI3K/Akt/mammalian target of rapamycin (mTOR) signaling [84].